Every figure below is the company's own, as filed. Nothing is estimated and
nothing is smoothed — a period the filing does not support is left blank rather than
drawn.
Quarters are the company's own, counted from its financial
year ending 09-30.
Amounts in USD.
Revenue Quarterly
0
2.5M
5M
7.5M
Q4 '21: 3M
Q1 '22: 4.2M
Q2 '22: 6.1M
Q3 '22: 4.3M
Q4 '22: 3.6M
Q1 '23: 5.3M
Q2 '23: 4.4M
Q3 '23: 2.9M
Q4 '23: 779.7K
Q1 '24: 891.2K
Q2 '24: 929.6K
Q3 '24: 472.8K
Q4 '24: 487.6K
Q1 '25: 870.3K
Q2 '25: 762.8K
Q3 '25: 304.4K
Q4 '25: 199.4K
Q1 '26: 565.4K
Q2 '26: 1M
Q3 '26: 605.3K
Q1 '22
Q4 '22
Q3 '23
Q2 '24
Q1 '25
Q4 '25
Q3 '26
Gross Profit Quarterly
0
900K
1.8M
2.7M
Q3 '21: 584.2K
Q4 '21: 1.1M
Q1 '22: 1.1M
Q2 '22: 2.5M
Q3 '22: 1M
Q4 '22: 416.8K
Q1 '23: 2.4M
Q2 '23: 1.8M
Q3 '23: 1.3M
Q4 '23: 79K
Q1 '24: 231.1K
Q2 '24: 295.7K
Q3 '24: 242.6K
Q4 '24: 202K
Q1 '25: 606.2K
Q2 '25: 395.5K
Q3 '25: 5.1K
Q1 '26: 315.4K
Q2 '26: 826.8K
Q3 '26: 447.1K
Q4 '21
Q3 '22
Q2 '23
Q1 '24
Q4 '24
Q3 '25
Q3 '26
Operating Income Quarterly
-21M
-14M
-7M
0
7M
14M
21M
Q4 '21: -4.6M
Q1 '22: -4.7M
Q2 '22: -2.2M
Q3 '22: -2.9M
Q4 '22: -4.3M
Q1 '23: -1.2M
Q2 '23: -2.7M
Q3 '23: -2.9M
Q4 '23: -4.2M
Q1 '24: -3.8M
Q2 '24: -3.6M
Q3 '24: -3.3M
Q4 '24: -3.2M
Q1 '25: -3M
Q2 '25: -3.4M
Q3 '25: -3.7M
Q4 '25: -6M
Q1 '26: -18.7M
Q2 '26: -6.8M
Q3 '26: -3.2M
Q1 '22
Q4 '22
Q3 '23
Q2 '24
Q1 '25
Q4 '25
Q3 '26
Net Income Quarterly
-21M
-14M
-7M
0
7M
14M
21M
Q4 '21: -4.5M
Q1 '22: -4.7M
Q2 '22: -1.8M
Q3 '22: -1.1M
Q4 '22: -663.2K
Q1 '23: -3.8M
Q2 '23: 588.3K
Q3 '23: -3.1M
Q4 '23: -3.6M
Q1 '24: -1.1M
Q2 '24: -4.5M
Q3 '24: 1.9M
Q4 '24: -3.3M
Q1 '25: -2.6M
Q2 '25: -3.3M
Q3 '25: -3.9M
Q4 '25: -5.3M
Q1 '26: -18.6M
Q2 '26: -6.7M
Q3 '26: -4.7M
Q1 '22
Q4 '22
Q3 '23
Q2 '24
Q1 '25
Q4 '25
Q3 '26
Cost of Revenue Quarterly
0
1.5M
3M
4.5M
Q3 '21: 1.1M
Q4 '21: 2M
Q1 '22: 3.1M
Q2 '22: 3.7M
Q3 '22: 3.3M
Q4 '22: 3.1M
Q1 '23: 2.9M
Q2 '23: 2.6M
Q3 '23: 1.6M
Q4 '23: 700.7K
Q1 '24: 660.1K
Q2 '24: 634K
Q3 '24: 230.2K
Q1 '25: 264.1K
Q2 '25: 367.3K
Q3 '25: 299.3K
Q4 '25: 367.4K
Q1 '26: 250K
Q2 '26: 197.3K
Q3 '26: 158.2K
Q4 '21
Q3 '22
Q2 '23
Q1 '24
Q1 '25
Q4 '25
Q3 '26
Operating Cash Flow Quarterly
-6M
-4M
-2M
0
2M
4M
6M
Q4 '21: -4.7M
Q1 '22: -3.7M
Q2 '22: -261.9K
Q3 '22: -1.8M
Q4 '22: -3.3M
Q1 '23: -2.4M
Q2 '23: 214.4K
Q3 '23: -1.4M
Q4 '23: -2.7M
Q1 '24: -3.8M
Q2 '24: -3.2M
Q3 '24: -3.5M
Q4 '24: -3.2M
Q1 '25: -3.3M
Q2 '25: -3.2M
Q3 '25: -2.6M
Q4 '25: -3.1M
Q1 '26: -5.5M
Q2 '26: -2M
Q3 '26: -982.9K
Q1 '22
Q4 '22
Q3 '23
Q2 '24
Q1 '25
Q4 '25
Q3 '26
Free Cash Flow Quarterly
-6M
-4M
-2M
0
2M
4M
6M
Q3 '20: -3M
Q4 '20: -4M
Q1 '21: -4.5M
Q2 '21: -4.1M
Q3 '21: -1.8M
Q4 '21: -5.6M
Q1 '22: -3.8M
Q2 '22: -327.4K
Q3 '22: -1.8M
Q4 '22: -3.5M
Q1 '23: -2.4M
Q2 '23: 160K
Q3 '23: -1.4M
Q4 '23: -2.7M
Q3 '24: -3.5M
Q4 '24: -3.6M
Q1 '25: -3.4M
Q2 '25: -3.4M
Q3 '25: -2.6M
Q4 '25: -3.1M
Q4 '20
Q3 '21
Q2 '22
Q1 '23
Q4 '23
Q1 '25
Q4 '25
Operating cash flow minus capital expenditure.
Shares Outstanding Quarterly
0
350M
700M
1.1B
Q1 '14: 931.8M
Q2 '14: 951.2M
Q1 '21: 5.5M
Q2 '21: 7.2M
Q3 '21: 7.2M
Q1 '22: 7.5M
Q2 '22: 8.1M
Q3 '22: 9M
Q1 '23: 12.9M
Q2 '23: 645.4K
Q3 '23: 645.4K
Q1 '24: 683.7K
Q2 '24: 17.4K
Q3 '24: 1.6K
Q1 '25: 42K
Q2 '25: 118.2K
Q3 '25: 572K
Q1 '26: 8.9M
Q2 '26: 9.7M
Q3 '26: 8.4M
Q2 '14
Q3 '21
Q3 '22
Q3 '23
Q3 '24
Q3 '25
Q3 '26
Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.
EPS TTM
-350.00
0.00
350.00
700.00
1050.00
Q1 '20: -7.12
Q2 '20: -4.69
Q3 '20: -3.86
Q4 '20: -3.41
Q1 '21: -3.17
Q2 '21: -2.59
Q3 '21: -2.35
Q4 '21: -2.19
Q1 '22: -1.79
Q2 '22: -1.81
Q3 '22: -1.46
Q4 '22: -0.83
Q1 '23: -0.65
Q2 '23: 0.49
Q3 '23: -4.18
Q4 '23: -9.55
Q1 '24: -10.98
Q2 '24: -277.34
Q3 '24: 897.94
Q3 '26: 544.27
Q2 '20
Q1 '21
Q4 '21
Q3 '22
Q2 '23
Q1 '24
Q3 '26
The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.